DP's dog and pony show continues today at 7:30 p.m. eastern time at the BioInvestor Conference in San Fran. I get the reason he does these things, but am I correct in saying today's musings will be identical to those he gave last Friday in NYC?
nothing whatsoever, always good to get the word out; here is excerpt from complimentary article out today though looks like Eurozone crisis will blunt any upward movement today
Curis Inc. - More Than Skin Deep
10/25/2011 7:26 AM ET
(RTTNews) - Basal cell carcinoma, which is rarely fatal, is a type of skin cancer that occurs most frequently due to high sun exposure. It is estimated that about 2 million cases of basal cell carcinoma are diagnosed in the U.S. annually.
One oral candidate drug for inoperable basal cell carcinoma, which has advanced to NDA filing is Vismodegib, being developed under a deal between Roche subsidiary Genentech and Curis Inc. (CRIS: News ).